ContractStrategic Alliance Agreement • June 5th, 2009 • Elite Pharmaceuticals Inc /De/ • Pharmaceutical preparations • Jersey
SECOND AMENDMENT, dated as of June 1, 2009 (this “Second Amendment”), by and between Elite Pharmaceuticals, Inc., a Delaware corporation (the “Company”), on the one hand, and Epic Pharma, LLC, a Delaware limited liability company (the “Parent”), Epic Investments, LLC, a Delaware limited liability company (including its successors and assigns, the “Purchaser”), Ashok G. Nigalaye (“Nigalaye”) and Jeenarine Narine (together with Nigalaye, the “Principals”), on the other hand, relating to a certain STRATEGIC ALLIANCE AGREEMENT, dated as of March 18, 2009, as amended by that certain Amendment thereto dated as of April 30, 2009 (as amended, the “Alliance Agreement”; capitalized terms used herein and not otherwise defined have the meaning assigned to such terms in the Alliance Agreement).
